Table of Contents

company-logo

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, which utilizes iPSC as a starting material to generate gdNKT, a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT, a product candidate that consists of expanded gamma delta T cells, and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers. The company was incorporated in 2018 and is headquartered in Singapore.

CytoMed Therapeutics Dividend Announcement

• CytoMed Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on CytoMed Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

CytoMed Therapeutics Dividend History

CytoMed Therapeutics Dividend Yield

CytoMed Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing CytoMed Therapeutics stock? Use our calculator to estimate your expected dividend yield:

CytoMed Therapeutics Financial Ratios

P/E ratio-8.57
PEG ratio-0.09
P/B ratio4.45
ROE-45.89%
Payout ratio0.00%
Current ratio21.53
Quick ratio21.53
Cash Ratio16.75

CytoMed Therapeutics Dividend FAQ

Does CytoMed Therapeutics stock pay dividends?
CytoMed Therapeutics does not currently pay dividends to its shareholders.
Has CytoMed Therapeutics ever paid a dividend?
No, CytoMed Therapeutics has no a history of paying dividends to its shareholders. CytoMed Therapeutics is not known for its dividend payments.
Why doesn't CytoMed Therapeutics pay dividends?
There are several potential reasons why CytoMed Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will CytoMed Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While CytoMed Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is CytoMed Therapeutics a dividend aristocrat?
CytoMed Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is CytoMed Therapeutics a dividend king?
CytoMed Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is CytoMed Therapeutics a dividend stock?
No, CytoMed Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy CytoMed Therapeutics stocks?
To buy CytoMed Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy CytoMed Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.